Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gilbert Tang

Thoracic Surgery (Cardiothoracic Vascular Surgery) New York, NY Medical Doctor

NPI 1144524349 CMS profile 142772

1190 5Th Ave # Gp2w, Box 1028, New York, NY 10029

Open in the dashboard

General payments

$841,664

1,292 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$336,647 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gilbert Tang of New York, NY is reported in the CMS Open Payments database as having received $841,664 across 1,292 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $336,647 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $94,565 212
2024 General $135,733 271
2023 General $210,998 246
2022 General $104,025 187
2021 General $97,625 116
2020 General $97,098 76
2019 General $101,620 184

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gilbert Tang
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Gilbert Tang were reported at $94,565. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Gilbert Tang Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $101,620 $886 $178–$3,167 $163
2020 $97,098 $341 $108–$1,605 $114
2021 $97,625 $453 $125–$1,886 $132
2022 $104,025 $695 $180–$2,566 $149
2023 $210,998 $745 $205–$2,662 $160
2024 $135,733 $799 $214–$2,967 $164
2025 $94,565 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $489,127 509 payments
  2. Medtronic Vascular, Inc. $127,549 134 payments
  3. Abbott Laboratories $119,913 379 payments
  4. Edwards Lifesciences Corporation $57,797 176 payments
  5. Siemens Medical Solutions USA, Inc. $20,167 44 payments
  6. W. L. Gore & Associates, Inc. $15,619 18 payments
  7. Boston Scientific Corporation $5,948 18 payments
  8. Baylis Medical Company Inc $3,375 2 payments
  9. Philips Electronics North America Corporation $814 1 payment
  10. CryoLife, Inc. $757 3 payments
  11. Other $598 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $412,031 160 payments
  2. Consulting Fee $238,244 78 payments
  3. Travel and Lodging $103,481 187 payments
  4. Food and Beverage $52,712 851 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $25,000 8 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $9,000 4 payments
  7. Grant $1,113 3 payments
  8. Education $84 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $304,334 300 payments
  2. CoreValve Evolut Transcatheter Valve Systems $110,762 115 payments
  3. CoreValve Evolut Transcatheter Valve Systems $55,667 40 payments
  4. Mitra Clip system $48,639 80 payments
  5. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $48,247 27 payments
  6. MitraClip System $32,569 28 payments
  7. APOLLOTM $18,192 18 payments
  8. Product in Development $15,471 17 payments
  9. ACUSON SC2000 Diagnostic Ultrasound System $14,575 24 payments
  10. NAVITOR $13,464 46 payments
  11. Other $40,621 391 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$298,094

Medicare's payments for the services billed

Medicare patients

454

Average age 82

Services billed

1,087

213 women, 241 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Arthritis 57%
Diabetes 50%
Atrial fibrillation 50%
Chronic kidney disease 42%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,292 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record